Cantel Medical Corp (CMD.N)
CMD.N on New York Stock Exchange
85.33USD
15 Oct 2018
85.33USD
15 Oct 2018
Change (% chg)
$0.61 (+0.72%)
$0.61 (+0.72%)
Prev Close
$84.72
$84.72
Open
$84.47
$84.47
Day's High
$85.96
$85.96
Day's Low
$83.57
$83.57
Volume
83,665
83,665
Avg. Vol
98,786
98,786
52-wk High
$130.92
$130.92
52-wk Low
$83.53
$83.53
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jul '18 | 228.85 | 0.411 |
| Apr '18 | 217.27 | 0.435 | |
| Jan '18 | 213.03 | 0.576 | |
| Oct | 212.77 | 0.548 | |
| FY 2017 | Jul '17 | 205.50 | 0.407 |
| Apr '17 | 192.11 | 0.419 | |
| Jan '17 | 184.82 | 0.432 | |
| Oct | 187.73 | 0.450 | |
| FY 2016 | Jul '16 | 179.00 | 0.390 |
| Apr '16 | 173.70 | 0.336 | |
| Jan '16 | 158.27 | 0.369 | |
| Oct | 153.78 | 0.342 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jul-18 | 3 | 225.98 | 227.10 | 224.80 | -- |
| Quarter Ending Oct-19 | 2 | 260.65 | 272.30 | 249.00 | -- |
| Year Ending Jul-18 | 4 | 869.01 | 870.00 | 867.90 | -- |
| Year Ending Jul-19 | 3 | 945.30 | 964.00 | 932.90 | 975.04 |
| Year Ending Jul-20 | 4 | 1,051.65 | 1,115.29 | 1,003.30 | 1,022.90 |
| Earnings (per share) | |||||
| Quarter Ending Jul-18 | 2 | 0.61 | 0.62 | 0.60 | -- |
| Quarter Ending Oct-19 | 2 | 0.68 | 0.69 | 0.66 | -- |
| Year Ending Jul-18 | 3 | 2.52 | 2.56 | 2.49 | -- |
| Year Ending Jul-19 | 3 | 2.65 | 2.76 | 2.60 | 2.67 |
| Year Ending Jul-20 | 3 | 3.02 | 3.26 | 2.86 | 3.10 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 56.96 | 32.83 | 32.75 | |
| P/E High - Last 5 Yrs. | 47.58 | 42.50 | 45.42 | |
| P/E Low - Last 5 Yrs. | 27.86 | 20.31 | 24.25 | |
| Beta | 1.22 | 0.80 | 0.89 | |
| Price to Sales (TTM) | 5.27 | 7.37 | 5.74 | |
| Price to Book (MRQ) | 7.75 | 5.08 | 5.00 | |
| Price to Tangible Book (MRQ) | 46.14 | 18.29 | 6.57 | |
| Price to Cash Flow (TTM) | 38.72 | 21.92 | 23.28 | |
| % Owned Institutions | 86.64 | 5.71 | 2.26 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.14 | 1.04 | 1.51 | |
| Dividend Yield - 5 Year Avg | 0.21 | 1.22 | 1.52 | |
| Dividend 5 Year Growth Rate | 15.07 | 16.53 | 5.24 | |
| Payout Ratio(TTM) | 0.00 | 31.37 | 43.77 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 14.80 | 8.62 | 8.00 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 15.86 | 2.18 | 5.62 | |
| Sales - 5 Yr. Growth Rate | 14.79 | 8.66 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 4.19 | 47.56 | 20.60 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 18.87 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 17.32 | 19.08 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | 37.52 | 8.60 | 15.33 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.49 | 2.38 | 2.22 |
| Current Ratio (MRQ) | 2.41 | 3.12 | 3.03 |
| LT Debt to Equity (MRQ) | 24.05 | 30.83 | 12.55 |
| Total Debt to Equity (MRQ) | 24.05 | 37.47 | 16.89 |
| Interest Coverage (TTM) | 31.31 | 15.93 | 32.71 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.72 | 58.87 | 54.34 | |
| Gross Margin - 5 Yr. Avg. | 45.67 | 58.59 | 52.13 | |
| EBITD Margin (TTM) | 19.80 | -- | -- | |
| EBITD - 5 Yr. Avg | 19.23 | 23.24 | 10.68 | |
| Operating Margin (TTM) | 14.34 | 17.68 | 4.33 | |
| Operating Margin - 5 Yr. Avg. | 14.43 | 15.81 | 6.11 | |
| Pre-Tax Margin (TTM) | 13.79 | 17.33 | 5.20 | |
| Pre-Tax Margin - 5 Yr. Avg. | 13.91 | 15.98 | 6.52 | |
| Net Profit Margin (TTM) | 9.27 | 13.27 | 1.49 | |
| Net Profit Margin - 5 Yr. Avg. | 8.98 | 11.15 | 2.79 | |
| Effective Tax Rate (TTM) | 32.81 | 22.80 | 23.12 | |
| Effective Tax Rate - 5 Yr. Avg. | 35.41 | 28.61 | 23.98 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 329,549 | 26,486,486 | 859,711,668 | |
| Net Income/Employee (TTM) | 30,543 | 3,162,698 | 101,129,378 | |
| Receivable Turnover (TTM) | 7.55 | 5.10 | 5.87 | |
| Inventory Turnover (TTM) | 4.23 | 3.16 | 3.41 | |
| Asset Turnover (TTM) | 1.04 | 0.77 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 9.64 | 10.39 | 11.13 | |
| Return on Assets - 5 Yr. Avg. | 8.99 | 9.03 | 12.40 | |
| Return on Investment (TTM) | 11.17 | 13.82 | 14.60 | |
| Return on Investment - 5 Yr. Avg. | 10.31 | 11.72 | 16.13 | |
| Return on Equity (TTM) | 14.50 | 16.65 | 16.33 | |
| Return on Equity - 5 Yr. Avg. | 13.31 | 14.14 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 15.86 | 16.37 | 14.79 |
| EPS (TTM) % | 18.87 | 17.85 | 17.32 |
| Dividend % | -18.75 | 16.60 | 15.07 |
Note: Units in Millions of US Dollars
Performance for Cantel Medical Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 18.42 | 14.33 | 99 | 54 |
| 13 Week | 29.19 | 22.90 | 99 | 67 |
| 26 Week | 31.51 | 21.52 | 99 | 58 |
| 52 Week | 23.17 | 4.40 | 99 | 35 |
| YTD | 23.53 | 8.48 | 99 | 34 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 86.17% |
| # of Holders: | 385 |
| Total Shares Held: | 35,936,845 |
| 3 Mo. Net Change: | 160,131 |
| # New Positions: | 8 |
| # Closed Positions: | 2 |
| # Increased Positions: | 17 |
| # Reduced Positions: | 11 |
| # Net Buyers: | 6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.